Paper3203045
The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon.
Francis JL and 3 others. Br J Clin Pharmacol, 1988. Cited by 7 papers, by iCite.
Cite this record
ConductScience Library. The effect of nisoldipine on whole blood platelet aggregation in patients with Raynaud's phenomenon. Papers, record 3203045. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3203045
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcium Channel Blockers | Major topic |
| Nifedipine | Major topic |
| Platelet Aggregation | Major topic |
| Raynaud Disease | Major topic |
| Adult | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Nisoldipine |
Source PubMed
References21
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6449756 | Plasma exchange and platelet function in Raynaud's phenomenon. | Thromb Res | 1980 | https://conductscience.org/library/papers/6449756 | PubMed |
| 2 | 3939725 | An investigation into the effects of nifedipine and nimodipine on platelet function and vascular prostacyclin synthesis. | Drugs Exp Clin Res | 1985 | https://conductscience.org/library/papers/3939725 | PubMed |
| 3 | 6791297 | Effects of nifedipine (Adalat) on platelet function in vitro and in vivo. | Thromb Res | 1981 | https://conductscience.org/library/papers/6791297 | PubMed |
| 4 | 7101234 | Inhibition of platelet function of antiarrhythmic drugs, verapamil and disopyramide. | Thromb Haemost | 1982 | https://conductscience.org/library/papers/7101234 | PubMed |
| 5 | 6758188 | Difficulty in detecting inhibition of platelet aggregation by the impedance method. | Thromb Res | 1982 | https://conductscience.org/library/papers/6758188 | PubMed |
| 6 | 6849223 | The effects of nifedipine, a calcium antagonist, on platelet function. | Am Heart J | 1983 | https://conductscience.org/library/papers/6849223 | PubMed |
| 7 | 6314581 | Effect of the calcium-entry blocking agent nifedipine on activation of human platelets and comparison with verapamil. | Thromb Haemost | 1983 | https://conductscience.org/library/papers/6314581 | PubMed |
| 8 | 6229551 | Assessment of platelet function in patients with Raynaud's syndrome. | J Clin Pathol | 1984 | https://conductscience.org/library/papers/6229551 | PubMed |
| 9 | 6376801 | Effect of the calcium channel blocker nifedipine on Raynaud's phenomenon. A controlled double blind trial. | J Rheumatol | 1984 | https://conductscience.org/library/papers/6376801 | PubMed |
| 10 | 6206096 | Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. | J Clin Pathol | 1984 | https://conductscience.org/library/papers/6206096 | PubMed |
| 11 | 3155583 | Effects of nifedipine on platelet function. | Am Heart J | 1985 | https://conductscience.org/library/papers/3155583 | PubMed |
| 12 | 3838352 | [Inhibition of platelet aggregation and thromboxane formation by the calcium antagonist nisoldipine following a single oral dose of 10 mg. A double-blind study in healthy probands]. | Klin Wochenschr | 1985 | https://conductscience.org/library/papers/3838352 | PubMed |
| 13 | 2994701 | Effects of verapamil and nisoldipine on human platelets: in vivo and in vitro studies. | Br J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/2994701 | PubMed |
| 14 | 2412780 | Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders. | Drugs | 1985 | https://conductscience.org/library/papers/2412780 | PubMed |
| 15 | 3079628 | Critical evaluation of platelet aggregation in whole human blood. | Am J Clin Pathol | 1986 | https://conductscience.org/library/papers/3079628 | PubMed |
| 16 | 3912185 | The effects of nifedipine on platelet aggregation and plasma 6-keto-PGF1 alpha, and its interaction with indomethacin. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3912185 | PubMed |
| 17 | 3019374 | Calcium antagonists and their mode of action: an historical overview. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3019374 | PubMed |
| 18 | 3533127 | Clinical and rheological effects of nifedipine in Raynaud's phenomenon. | Br J Clin Pharmacol | 1986 | https://conductscience.org/library/papers/3533127 | PubMed |
| 19 | 3590105 | Improved assessment of impedance aggregometry using a microcomputer. | Thromb Res | 1987 | https://conductscience.org/library/papers/3590105 | PubMed |
| 20 | 3691593 | Nisoldipine in primary Raynaud's phenomenon. | Eur J Clin Pharmacol | 1987 | https://conductscience.org/library/papers/3691593 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26914257 | Calcium channel blockers for primary Raynaud's phenomenon. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/26914257 | PubMed |
| 8841741 | Nisoldipine coat-core. A review of its pharmacology and therapeutic efficacy in hypertension. | Drugs | 1996 | https://conductscience.org/library/papers/8841741 | PubMed |
| 3065058 | Nisoldipine. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of angina pectoris, hypertension and related cardiovascular disorders. | Drugs | 1988 | https://conductscience.org/library/papers/3065058 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3203045
GET https://conductscience.org/api/papers/v1/3203045/references?page=2